Literature DB >> 22534246

Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia.

Heike L Rittner1, Salah Amasheh, Rabih Moshourab, Dagmar Hackel, Reine-Solange Yamdeu, Shaaban A Mousa, Michael Fromm, Christoph Stein, Alexander Brack.   

Abstract

BACKGROUND: Peripheral application of opioids reduces inflammatory pain but is less effective in noninflamed tissue of rats and human patients. Hypertonic solutions can facilitate the antinociceptive activity of hydrophilic opioids in noninflamed tissue in vivo. However, the underlying mechanisms are not well understood. We hypothesized that the enhanced efficacy of opioids may be because of opening of the perineurial barrier formed by tight junction-proteins like claudin-1.
METHODS: Male Wistar rats were treated intraplantarly with 10% NaCl. Pain behavior (n = 6) and electrophysiological recordings (n = 9 or more) from skin-nerve preparations after local application of the opioid [d-Ala2,N-Me-Phe4,Gly5-ol]enkephalin (DAMGO) were explored. Tight junction-proteins as well as permeability of the barrier were examined by immunohistochemistry and Western blot (n = 3 or more).
RESULTS: Local administration of 10% NaCl facilitated increased mechanical nociceptive thresholds in response to DAMGO, penetration of horseradish peroxidase into the nerve, as well as a reduced response of C- but not Aδ-nociceptors to mechanical stimulation after application of DAMGO in the skin-nerve preparation. In noninflamed paw tissue, claudin-1 was expressed in the epidermis, blood vessels, and the perineurium, surrounding neurons immunoreactive for calcitonin gene-related peptide or protein gene product 9.5. Claudin-1 but not claudin-5 or occludin was significantly reduced after pretreatment with 10% NaCl. Intraplantar application of a metalloproteinase inhibitor (GM6001) completely reversed these effects.
CONCLUSION: Hypertonic saline opens the perineurial barrier via metalloproteinase activation and claudin-1 regulation, thereby allowing access of hydrophilic drugs to peripheral opioid receptors. This principle may be used to specifically target hydrophilic drugs to peripheral neurons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22534246     DOI: 10.1097/ALN.0b013e318256eeeb

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

Review 1.  Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

Authors:  Evan B Stubbs
Journal:  Exp Neurol       Date:  2020-06-17       Impact factor: 5.330

2.  Proteins and Signaling Pathways Response to Dry Needling Combined with Static Stretching Treatment for Chronic Myofascial Pain in a RAT Model: An Explorative Proteomic Study.

Authors:  Lihui Li; Qiangmin Huang; Marco Barbero; Lin Liu; Thitham Nguyen; Anle Xu; Lijuan Ji
Journal:  Int J Mol Sci       Date:  2019-01-29       Impact factor: 5.923

3.  Quantified Morphology of the Cervical and Subdiaphragmatic Vagus Nerves of Human, Pig, and Rat.

Authors:  Nicole A Pelot; Gabriel B Goldhagen; Jake E Cariello; Eric D Musselman; Kara A Clissold; J Ashley Ezzell; Warren M Grill
Journal:  Front Neurosci       Date:  2020-11-04       Impact factor: 4.677

4.  Targeting pain and inflammation by peripherally acting opioids.

Authors:  Christoph Stein
Journal:  Front Pharmacol       Date:  2013-09-23       Impact factor: 5.810

Review 5.  Barriers of the peripheral nerve.

Authors:  Sirkku Peltonen; Maria Alanne; Juha Peltonen
Journal:  Tissue Barriers       Date:  2013-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.